|
業務類別
|
-- |
|
業務概覽
|
EOM Pharmaceutical Holdings Inc is a clinical-stage biotechnology company that is focused on developing drugs with the potential to transform therapeutic paradigms and improve the lives of patients suffering from debilitating and sometimesdeadly diseases. Its pipeline includes compound EOM613, an investigational novel dynamically dual-acting immunomodulator. EOM613 is a peptide nucleic-acid solution with both anti-inflammatory and pro-inflammatory broad-spectrum cytokine effects. |
| 公司地址
| 136 Summit Avenue, Suite 100, Montvale, NJ, USA, 07645 |
| 電話號碼
| +1 201 351-0605 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.eompharma.com |
| 員工數量
| 4 |
| Mr. Gary S. Titus |
Chairman of the Board and Secretary |
-- |
14/03/2018 |
|
|
| Dr. Rahul Singhvi |
Independent Director |
14/03/2018 |
| Mr. Gary S. Titus |
Chairman of the Board and Secretary |
14/03/2018 |
| Dr. John S. Yu,M.D. |
Director |
14/03/2018 |
|
|
|
|
